123707 Apr 2026

Governed by California Health and Safety Code § 123707 , the Infant Botulism Treatment and Prevention Unit isn't just a regulatory body—it’s a manufacturer. It is the primary entity authorized to handle the distribution and licensure of Botulism Immune Globulin Intravenous (Human) , often referred to by its trade name, BabyBIG®.

The number refers to California Health and Safety Code § 123707 , which governs the Infant Botulism Treatment and Prevention Unit . This unit is responsible for the manufacture, distribution, and licensure of Botulism Immune Globulin Intravenous (Human) , a life-saving treatment for infants.

: To ensure rapid response, the department is exempt from standard competitive bidding for the testing and distribution of the treatment. 123707

AI responses may include mistakes. For legal advice, consult a professional. Learn more California Code, Health and Safety Code - HSC § 123707

Below is a feature article written about this unit and its critical mission. Governed by California Health and Safety Code §

Infant botulism often stems from environmental spores found in soil or honey. For parents, the sudden onset of "floppy baby syndrome" is a nightmare. The unit established by Section 123707 acts as a global safeguard, ensuring that the specialized antibodies needed to neutralize botulinum toxins are always available, tested, and ready for the infants who need them most.

: Because cases of infant botulism can fluctuate by up to 60% annually , any unspent funds at the end of a fiscal year are automatically carried forward. This "rainy day" provision ensures that when an outbreak occurs, the resources are already in place. This unit is responsible for the manufacture, distribution,

The law provides this unit with extraordinary flexibility because the stakes are so high. According to the statute: